0001806643-20-000001.txt : 20200317 0001806643-20-000001.hdr.sgml : 20200317 20200317140932 ACCESSION NUMBER: 0001806643-20-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200317 DATE AS OF CHANGE: 20200317 EFFECTIVENESS DATE: 20200317 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Tavros Therapeutics, Inc. CENTRAL INDEX KEY: 0001806643 IRS NUMBER: 843470074 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-363041 FILM NUMBER: 20720468 BUSINESS ADDRESS: STREET 1: 701 WEST MAIN ST., SUITE 200 CITY: DURHAM STATE: NC ZIP: 27701 BUSINESS PHONE: 919-602-2631 MAIL ADDRESS: STREET 1: 701 WEST MAIN ST., SUITE 200 CITY: DURHAM STATE: NC ZIP: 27701 D 1 primary_doc.xml X0708 D LIVE 0001806643 Tavros Therapeutics, Inc. 701 WEST MAIN ST., SUITE 200 DURHAM NC NORTH CAROLINA 27701 919-602-2631 DELAWARE None None Corporation true 2019 Eoin McDonnell c/o Tavros Therapeutics, Inc. 701 West Main St., Suite 200 Durham NC NORTH CAROLINA 27701 Executive Officer Director Kris Wood c/o Tavros Therapeutics, Inc. 701 West Main St., Suite 200 Durham NC NORTH CAROLINA 27701 Director Other Technology Decline to Disclose 06b false 2020-03-02 true true false 0 3000000 999996 2000004 false 1 0 0 0 Other than the payment of salaries and other compensation and benefits and reimbursement of expenses, no officer, director, partner, manager or promoter will receive any payments from the proceeds of this offering. false Tavros Therapeutics, Inc. /s/ Eoin McDonnell Eoin McDonnell Chief Executive Officer 2020-03-17